Analysis | Metabolite Name | Measured Value | Units | Group | Timepoint | Gender | Age at start of study (years) |
---|---|---|---|---|---|---|---|
GC POSITIVE ION MODE | phenylethylamine | 149 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 7 |
GC POSITIVE ION MODE | phenylethylamine | 172 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | phenylethylamine | 269 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 10 |
GC POSITIVE ION MODE | phenylethylamine | 272 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
GC POSITIVE ION MODE | phenylethylamine | 659 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 7 |
GC POSITIVE ION MODE | phenylethylamine | 726 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
GC POSITIVE ION MODE | phenylethylamine | 1083 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
GC POSITIVE ION MODE | phenylethylamine | 1179 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 7 |
GC POSITIVE ION MODE | phenylethylamine | 1204 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 5 |
GC POSITIVE ION MODE | phenylethylamine | 1666 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 9 |
GC POSITIVE ION MODE | phenylethylamine | 2066 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 7 |
GC POSITIVE ION MODE | phenylethylamine | 2115 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
GC POSITIVE ION MODE | phenylethylamine | 2205 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 10 |
GC POSITIVE ION MODE | phenylethylamine | 2605 | Counts | Synbiotic | Recovery (days 68-70) | Female spayed | 5 |
GC POSITIVE ION MODE | phenylethylamine | 2774 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
GC POSITIVE ION MODE | phenylethylamine | 3035 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
GC POSITIVE ION MODE | phenylethylamine | 3191 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
GC POSITIVE ION MODE | phenylethylamine | 3326 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | phenylethylamine | 3513 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
GC POSITIVE ION MODE | phenylethylamine | 3590 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
GC POSITIVE ION MODE | phenylethylamine | 3823 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | phenylethylamine | 3910 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | phenylethylamine | 4038 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | phenylethylamine | 4197 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | phenylethylamine | 4231 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | phenylethylamine | 4366 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 5 |
GC POSITIVE ION MODE | phenylethylamine | 4384 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | phenylethylamine | 4403 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | phenylethylamine | 4813 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | phenylethylamine | 4864 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | phenylethylamine | 4867 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 5 |
GC POSITIVE ION MODE | phenylethylamine | 5721 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 5 |
GC POSITIVE ION MODE | phenylethylamine | 5753 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 5 |
GC POSITIVE ION MODE | phenylethylamine | 5911 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 7 |
GC POSITIVE ION MODE | phenylethylamine | 5958 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 7 |
GC POSITIVE ION MODE | phenylethylamine | 6717 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 7 |
GC POSITIVE ION MODE | phenylethylamine | 6877 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
GC POSITIVE ION MODE | phenylethylamine | 7293 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 10 |
GC POSITIVE ION MODE | phenylethylamine | 7307 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
GC POSITIVE ION MODE | phenylethylamine | 7558 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 9 |
GC POSITIVE ION MODE | phenylethylamine | 7687 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 7 |
GC POSITIVE ION MODE | phenylethylamine | 9099 | Counts | Synbiotic | Recovery (days 68-70) | Female spayed | 10 |
GC POSITIVE ION MODE | phenylethylamine | 9212 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 7 |
GC POSITIVE ION MODE | phenylethylamine | 9666 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
GC POSITIVE ION MODE | phenylethylamine | 10632 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 5 |
GC POSITIVE ION MODE | phenylethylamine | 12671 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 5 |
GC POSITIVE ION MODE | phenylethylamine | 13070 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
GC POSITIVE ION MODE | phenylethylamine | 13920 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 7 |
GC POSITIVE ION MODE | phenylethylamine | 15118 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 7 |
GC POSITIVE ION MODE | phenylethylamine | 16982 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 10 |
GC POSITIVE ION MODE | phenylethylamine | 17065 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 10 |
GC POSITIVE ION MODE | phenylethylamine | 18146 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 9 |
GC POSITIVE ION MODE | phenylethylamine | 36081 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
GC POSITIVE ION MODE | phenylethylamine | 60753 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 10 |